You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 139 No. 1, January 2003 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Correspondence
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Hair Changes in Women From the Women's Interagency HIV Study

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Various hair changes have been reported in human immunodeficiency virus (HIV)–infected patients.1-4 The prevalence of these changes, however, has not been studied.

Methods

The Women's Interagency HIV Study (WIHS) is a multicenter prospective study of women in the United States who have HIV or are at risk for HIV disease.5 During the evaluation period of April 2000 through September 2000 a hair questionnaire was administered to 336 HIV-infected and 91 non–HIV-infected (HIV-noninfected) women in the Northern California WIHS.

The questionnaire focused on personal and family history of hair loss, current assessment of hair density, change in hair characteristics, eyebrow and eyelash length, and hair grooming practices. Information on demographics, medication use, and laboratory values was also assessed. Women infected with HIV who were taking a combination of antiretroviral medications that included a protease inhibitor or nonnucleoside reverse transcriptase inhibitor were labeled as being on highly active antiretroviral therapy (HAART).

For bivariate . . . [Full Text of this Article]


Results

Comment


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.